Retension Pharmaceuticals, Inc. Common Stock (RTSN NASDAQ) stock market data APIs
$12.3475
-0.52(-4.2%)
as of November 12, 2026
Try our APIs with
free plan!
Retension Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Prev. Close
12.3475
Open
11.8238
High
12.4597
Low
11.5766
52 wk Range
9.66-3150
Market Cap
101 M
Shares Outstanding
8 332 K
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Retension Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get Retension Pharmaceuticals, Inc. Common Stock Fundamental Data
Retension Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Retension Pharmaceuticals, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Retension Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Retension Pharmaceuticals, Inc. Common Stock News
New
Cloudflare upgraded, Marvell downgraded: Wall Street's top analyst calls
Cloudflare upgraded, Marvell downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research call...
Retension Pharmaceuticals prices upsized IPO at $12 per share
[IPO Concept with Stock Market Graphs] AlexSecret * Retension Pharmaceuticals (RTSN [https://seekingalpha.com/symbol/RTSN]) priced its upsized IPO at $12 per share. * The clinical-stage biopharm...
Get Retension Pharmaceuticals, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.